Molecular Formula | C15H12O |
Molar Mass | 208.26 |
Density | 1.156g/mLat 25°C(lit.) |
Melting Point | 32-34°C(lit.) |
Boling Point | 148°C0.3mm Hg(lit.) |
Flash Point | >230°F |
Water Solubility | insoluble |
Solubility | 0.03g/l |
Vapor Presure | 6.35E-06mmHg at 25°C |
Appearance | Liquid or Low Melting Solid |
Color | Clear yellow |
BRN | 1454355 |
Storage Condition | Store below +30°C. |
Refractive Index | n20/D 1.6332(lit.) |
Physical and Chemical Properties | Light yellow crystalline powder |
Use | Used as a pharmaceutical Intermediate |
Hazard Symbols | Xi - Irritant |
Risk Codes | 36/37/38 - Irritating to eyes, respiratory system and skin. |
Safety Description | S24/25 - Avoid contact with skin and eyes. S36 - Wear suitable protective clothing. S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. |
WGK Germany | 3 |
RTECS | HP1149700 |
TSCA | Yes |
HS Code | 29143900 |
Toxicity | LD50 orally in Rabbit: 2511 mg/kg LD50 dermal Rat > 2000 mg/kg |
NIST chemical information | information provided by: webbook.nist.gov (external link) |
EPA chemical substance information | information provided by: ofmpeb.epa.gov (external link) |
Use | pharmaceutical intermediates for the synthesis of drug amitriptyline. used as pharmaceutical intermediates |
production method | obtained by cyclization of O-β-phenylethylbenzoic acid. |